Vor Biopharma Ownership | Who Owns Vor Biopharma?

Overview Forecast RevenueFinancials Chart

Vor Biopharma Ownership Summary

Vor Biopharma is owned by 45.52% institutional investors, 42.84% insiders, and 11.63% retail investors. Ra capital management is the largest institutional shareholder, holding 31.65% of VOR shares. Fidelity Growth Compy Commingled Pl O is the top mutual fund, with 3.10% of its assets in Vor Biopharma shares.

VOR Ownership Benchmark

Type	Name	% Inst	% Insiders	% Retail
Stock	Vor Biopharma	45.52%	42.84%	11.63%
Sector	Healthcare Stocks	488.17%	11.08%	-399.26%
Industry	Biotech Stocks	306.59%	11.10%	-217.69%

Institutional Shareholders

Top Institutional Shareholders by Total Shares

Holder	Shares	% Holding	Value
Ra capital management	39.65M	31.65%	$64.23M
Fmr	6.42M	9.38%	$7.13M
5am venture management	6.36M	9.29%	$7.06M
Vanguard group	1.94M	2.84%	$2.16M
Johnson & johnson	1.07M	0.86%	$1.14M
Renaissance	529.50K	0.77%	$587.75K
Blackrock	497.70K	0.73%	$497.70K
Geode capital management	422.14K	0.62%	$468.71K
Northern trust	380.74K	0.56%	$380.74K
Sarissa capital management lp	508.02K	0.41%	$822.99K

Top Institutional Shareholders by % of Total Assets

Holder	Shares	% Assets	Value
5am venture management	6.36M	1.69%	$7.06M
Ra capital management	39.65M	1.08%	$64.23M
Sarissa capital management lp	508.02K	0.53%	$822.99K
Johnson & johnson	1.07M	0.34%	$1.14M
Scientech research	403.86K	0.16%	$654.25K
Two sigma securities	94.39K	0.02%	$152.92K
Trustees of columbia university in the city of new york	91.91K	0.02%	$102.02K
Hrt financial lp	474.57K	0.00%	$768.00K
Xtx topco	40.94K	0.00%	$66.33K
Bollard group	55.55K	0.00%	$90.00K

Top Buyers

Holder	Shares	% Assets	Change
Hrt financial lp	474.57K	0.00%	474.57K
Scientech research	403.86K	0.16%	403.86K
Susquehanna group, llp	115.03K	-	115.03K
Two sigma securities	94.39K	0.02%	94.39K
Trustees of columbia university in the city of new york	91.91K	0.02%	91.91K

Top Sellers

Holder	Shares	% Assets	Change
Paradigm biocapital advisors lp	-	-	-6.46M
Hudson bay capital management lp	-	-	-2.47M
Blackrock	497.70K	-	-1.75M
Woodline partners lp	-	-	-1.11M
Artal group	-	-	-1.00M

New Positions

Holder	Shares	% Assets	Change	Value
Hrt financial lp	474.57K	0.00%	474.57K	$768.00K
Scientech research	403.86K	0.16%	403.86K	$654.25K
Trustees of columbia university in the city of new york	91.91K	0.02%	91.91K	$102.02K
Sei investments	17.60K	-	17.60K	$17.60K
Aqr capital management	11.20K	-	11.20K	$11.20K

Sold Out

Holder	Change
Nelson, van denburg & campbell wealth management group	-6.00
Citigroup	-6.00
Point72 (difc)	-26.00
Nisa investment advisors	-45.00
Citadel advisors	-100.00

Institutional Ownership Trends

Date	Holdings	Change %	Shares	Change %	Ownership	Change %	Increased Position	Change %	Decreased Position	Change %
Jun 30, 2025	41	-2.38%	57,027,241	7.15%	45	2.50%	21	16.67%	11	-35.29%
Mar 31, 2025	44	-16.98%	60,090,600	-1.40%	48	0.61%	18	-10.00%	18	12.50%
Dec 31, 2024	52	-5.45%	60,931,305	27.38%	88	1.82%	20	11.11%	16	-11.11%
Sep 30, 2024	55	-19.12%	47,833,717	-12.27%	69	1.09%	19	-51.28%	18	5.88%
Jun 30, 2024	68	-2.86%	54,521,316	-7.51%	80	1.04%	39	34.48%	17	-19.05%

Top Mutual Funds Shareholders

Holder	Shares	% Holding	Change
Fidelity Growth Compy Commingled Pl O	2.12M	3.10%	-
Fidelity Growth Compy Commingled Pl S	1.96M	1.57%	-207.80K
Vanguard US Total Market Shares ETF	1.39M	1.11%	-
Vanguard Total Stock Mkt Idx Inv	1.36M	1.07%	-29.89K
Fidelity Growth Company Fund	1.27M	1.02%	-140.15K
Fidelity Select Biotechnology	614.60K	0.90%	-
Fidelity VIP Growth Initial	618.39K	0.49%	-
Fidelity Capital Appreciation	610.40K	0.49%	-
Fidelity Advisor Equity Growth I	474.17K	0.38%	-
Fidelity Growth Company K6	438.61K	0.35%	-43.30K

Recent Insider Transactions

Date	Name	Role	Activity	Value
Sep 05, 2025	Reprogrammed Interchange LLC	-	Sell	$787.28K
Sep 03, 2025	Reprogrammed Interchange LLC	-	Sell	$1.11M
Sep 04, 2025	Reprogrammed Interchange LLC	-	Sell	$873.64K
Aug 27, 2025	Reprogrammed Interchange LLC	-	Sell	$1.23M
Aug 28, 2025	Reprogrammed Interchange LLC	-	Sell	$1.62M

Insider Transactions Trends

Date	Buy	Sell
2025 Q3	-	7
2025 Q2	-	-
2025 Q1	-	2
2024 Q4	2	1
2024 Q3	-	-

VOR Ownership FAQ

Who Owns Vor Biopharma?

Vor Biopharma shareholders are primarily institutional investors at 45.52%, followed by 42.84% insiders and 11.64% retail investors. The average institutional ownership in Vor Biopharma's industry, Biotech Stocks , is 306.59%, which Vor Biopharma falls below.

Who owns the most shares of Vor Biopharma?

Vor Biopharma’s largest shareholders are Ra capital management (39.65M shares, 31.65%), Fmr (6.42M shares, 9.38%), and 5am venture management (6.36M shares, 9.29%). Together, they hold 50.32% of Vor Biopharma’s total shares outstanding.

Does Blackrock own Vor Biopharma?

Yes, BlackRock owns 0.73% of Vor Biopharma, totaling 497.7K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 497.7K$. In the last quarter, BlackRock decreased its holdings by -1.75M shares, a -77.86% change.

Who is Vor Biopharma’s biggest shareholder by percentage of total assets invested?

5am venture management is Vor Biopharma’s biggest shareholder by percentage of total assets invested, with 1.69% of its assets in 6.36M Vor Biopharma shares, valued at 7.06M$.

Who is the top mutual fund holder of Vor Biopharma shares?

Fidelity Growth Compy Commingled Pl O is the top mutual fund holder of Vor Biopharma shares, with 3.10% of its total shares outstanding invested in 2.12M Vor Biopharma shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis

Discover trending investment themes
Find your next best investment
Research stocks using tools